Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 77715

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 21, 2017
Product types
Food
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Duy Drugs Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Food Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

food · product 1 of 2

Viva ben Femenine Supplement, Dietary Supplement 30 Softgels

F-3355-2017
Recall number
F-3355-2017
Initiated
July 21, 2017
Classification
Class II
Status
Terminated
Recalling firm
Duy Drugs Inc.
Quantity
1800 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.

Code information

Lot No. 0117221

Distribution pattern

Domestic distribution only.

food · product 2 of 2

Cardiovid Plus, Cardiovascular Active Dietary Supplement, 60 Softgels

F-3356-2017
Recall number
F-3356-2017
Initiated
July 21, 2017
Classification
Class II
Status
Terminated
Recalling firm
Duy Drugs Inc.
Quantity
411 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.

Code information

Lot No. 1701

Distribution pattern

Domestic distribution only.